Nurdan Yıldız

Nurdan Yıldız

Auto-generated profile, based on publicly available information

Nurdan Yıldız

Department of Pediatric Nephrology, Marmara University School of Medicine, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2013 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
CCCengiz Candan
Cengiz Candan
NCNur Canpolat
Nur Canpolat
SGSelman Gokalp
Selman Gokalp
NYNurdan Yıldız
Nurdan Yıldız
PTPınar Turhan
Pınar Turhan
SCSalim Caliskan
Salim Caliskan

16 September 2022 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
NCNeslihan Cicek
Neslihan Cicek
HAHarika Alpay
Harika Alpay
SGSercin Guven
Sercin Guven
CACeren Alavanda
Ceren Alavanda
ÖTÖzde Nisa Türkkan
Özde Nisa Türkkan
IGIbrahim Gokce
Ibrahim Gokce

1 November 2021 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
ZYZeynep Nagehan Yuruk Yildirim
Zeynep Nagehan Yuruk Yildirim
SASEBAHAT USTA AKGUL
SEBAHAT USTA AKGUL
HAHarika Alpay
Harika Alpay
BABagdagul Aksu
Bagdagul Aksu
FOFatma Savran Oguz
Fatma Savran Oguz
AYAlev Yilmaz
Alev Yilmaz
Various molecular and cellular processes are involved in renal fibrosis, such as oxidative stress, inflammation, endothelial cell injury, and apoptosis. Heat shock proteins (HSPs) are implicated in the progression of chronic kidney disease (CKD). Our aim was to evaluate changes in urine and serum HSP levels over time and their relationships with the clinical parameters of CKD in children. In total, 117 children with CKD and 56 healthy children were examined. The CKD group was followed up prospectively for 24 months. Serum and urine HSP27, HSP40, HSP47, HSP60, HSP70, HSP72, and HSP90 levels and serum anti-HSP60 and anti-HSP70 levels were measured by ELISA at baseline, 12 months, and 24 months. The urine levels of all HSPs and the serum levels of HSP40, HSP47, HSP60, HSP70, anti-HSP60, and anti-HSP70 were higher at baseline in the CKD group than in the control group. Over the months, serum HSP47 and HSP60 levels steadily decreased, whereas HSP90 and anti-HSP60 levels steadily increased. Urine HSP levels were elevated in children with CKD; however, with the exception of HSP90, they decreased over time. In conclusion, our study demonstrates that CKD progression is a complicated process that involves HSPs, but they do not predict CKD progression. The protective role of HSPs against CKD may weaken over time, and HSP90 may have a detrimental effect on the disease course.

25 March 2015 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
NYNurdan Yıldız
Nurdan Yıldız
HAHarika Alpay
Harika Alpay
HTHalil Tuğtepe
Halil Tuğtepe
ZKZarife Nigar Özdemir Kumral
Zarife Nigar Özdemir Kumral
DADilek Akakın
Dilek Akakın
BYBerrak Yegen
Berrak Yegen

20 May 2021 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
NCNeslihan Cicek
Neslihan Cicek
NYNurdan Yildiz
Nurdan Yildiz
RARuslan Asadov
Ruslan Asadov
AYAyse Deniz Yucelten
Ayse Deniz Yucelten
HTHalil Tugtepe
Halil Tugtepe
HAHarika Alpay
Harika Alpay
Background: Several renal and urinary tract complications have been reported in patients with epidermolysis bullosa. Objective: This study investigated kidney and urinary tract involvement in patients with epidermolysis bullosa. Patients and Methods: Patients with epidermolysis bullosa in treatment at the Dermatology Unit were included in the study. Glomerular and tubular functions were investigated. Results: The study included 16 patients (4 females, 12 males) of mean 11.1 years (SD = 8.1 years). Estimated GFR was normal in all patients except one with end-stage renal disease. Excluding this patient, the urinary albumin/creatinine ratio and the fractional excretion of sodium were normal. The mean beta-2 microglobulin/creatinine ratio was 278.8 µg/g, and it was abnormally high in 2 patients. The mean tubular phosphorus reabsorption was 92.6%; it was abnormally low in 1 patient. Severe kidney or urinary tract involvement was present in 2 patients with recessive dystrophic EB-generalized severe (RDEB-GS): one patient had obstructive bullous lesions in the urethra; the other had end-stage renal disease secondary to focal segmental glomerulosclerosis and was on peritoneal dialysis for 3 years. Conclusions: Assessment for renal and urinary tract involvement should become a routine part of the evaluation of patients with any type of EB, but especially of patients with RDEB-GS. Patients with mild tubular dysfunction need long-term follow-up to detect early deterioration of renal function.

2 December 2022 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
RGRuveyda Gulmez
Ruveyda Gulmez
DÖDoğukan Özbey
Doğukan Özbey
AAAyse Agbas
Ayse Agbas
BABagdagul Aksu
Bagdagul Aksu
NYNurdan Yildiz
Nurdan Yildiz
SCSalim Caliskan
Salim Caliskan
Background Compared with the general population, the immune response to COVID-19 mRNA vaccines is lower in adult kidney transplant recipients (KTRs). However, data is limited for pediatric KTRs. In this study, we aimed to assess humoral and cellular immune responses to the COVID-19 mRNA vaccine in pediatric KTRs. Methods This multicenter, prospective, case–control study included 63 KTRs (37 male, aged 12–21 years), 19 dialysis patients, and 19 controls. Humoral (anti-SARS-CoV2 IgG, neutralizing Ab (nAb)) and cellular (interferon-gamma release assay (IGRA)) immune responses were assessed at least one month after two doses of BNT162b2 mRNA vaccine. Results Among COVID-19 naïve KTRs (n = 46), 76.1% tested positive for anti-SARS-CoV-2 IgG, 54.3% for nAb, and 63% for IGRA. Serum levels of anti-SARS-CoV-2 IgG and nAb activity were significantly lower in KTRs compared to dialysis and control groups (p < 0.05 for all). Seropositivity in KTRs was independently associated with shorter transplant duration (p = 0.005), and higher eGFR (p = 0.007). IGRA titer was significantly lower than dialysis patients (p = 0.009). Twenty (43.4%) KTRs were positive for all immune parameters. Only four of 11 seronegative KTRs were IGRA-positive. COVID-19 recovered KTRs had significantly higher anti-SARS-CoV-2 IgG and nAb activity levels than COVID-19 naïve KTRs (p = 0.018 and p = 0.007, respectively). Conclusions The humoral and cellular immune responses to SARS-CoV-2 mRNA BNT162b2 vaccine are lower in pediatric KTRs compared to dialysis patients. Further prospective studies are required to demonstrate the clinical efficacy of the mRNA vaccine in KTRs. This prospective study was registered in ClinicalTrials.gov (NCT05465863, registered retrospectively at 20.07.2022). Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information.